Patient Facts Study Results Part II: SSDQA Comparison

- National, Seattle, and Nationwide have noticeable longitudinal variation compared to the rest of the network, which generally behaves relatively consistently. - For most domains & visit types, Seattle's data seems to have an inflection point around 2017/2018 where the data develops an upward trend and eventually reaches a point where it aligns with the rest of the network. A notable exception to this trend is ANC labs at ED visits, where Seattle remains at levels below network average even after the inflection point. - National has little to no procedure or prescription drug data across the entire time series for each of the visit type stratifications. - Nationwide generally trends lower than the rest of the network across all hematology specialty visits.